Before you sell to, join or invest in Avicenna Biosciences, Inc.
MentionFox check on Avicenna Biosciences, Inc.: only 1 source on file so far (checked 10 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/avicenna-biosciences-inc-form-d-22000002
Check Avicenna Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Avicenna Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2022-12-30.
Avicenna Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 30, 2022. The filing reports $3M sold. Its industry group is Biotechnology. It names Christopher Meldrum (Executive Officer, Director), Thomas Kaiser (Executive Officer, Director), Pieter Burger (Director) (SEC Form D, December 30, 2022).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Avicenna Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2022-12-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Avicenna Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Avicenna Biosciences, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Avicenna Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Avicenna Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Avicenna Biosciences, Inc. →Get the full cited report on Avicenna Biosciences, Inc.
What the filing shows about Avicenna Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Avicenna Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Avicenna Biosciences, Inc.'s address as 701 West Main Street, Suite 200, Durham, NC 27701.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Avicenna Biosciences, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Avicenna Biosciences, Inc. See pricing
Avicenna Biosciences, Inc. is a registered filer with the SEC (CIK 1824034) and has filed since 2022-10-27. 6 filings are on record, the latest on 2025-10-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Avicenna Biosciences, Inc.'s Form D of 2022-12-30 names Christopher Meldrum, Thomas Kaiser, Pieter Burger and 2 more as its officers, directors or promoters.
Its new offerings report $15.02M sold across 4 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 755 filings in Biotechnology, totalled by week.
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
Christopher Meldrum is named as Executive Officer and Director on the Form D that Avicenna Biosciences, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
Thomas Kaiser is named as Executive Officer and Director on the Form D that Avicenna Biosciences, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
Pieter Burger is named as Director on the Form D that Avicenna Biosciences, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
John Hamer is named as Director on the Form D that Avicenna Biosciences, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
Dennis Langer is named as Director on the Form D that Avicenna Biosciences, Inc. filed with the SEC on 30 December 2022, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2022-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Avicenna Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Avicenna Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Avicenna Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Avicenna Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Avicenna Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Avicenna Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/avicenna-biosciences-inc-form-d-22000002